EP4106750A1 — Method of treating bacterial infections and pharmaceutical composition for treating bacterial infections
Assigned to Institut National de Recherche pour lAgriculture lAlimentation et lEnvironnement · Expires 2022-12-28 · 3y expired
What this patent protects
The invention relates to a compound having the general formula (I), or one of the pharmaceutically acceptable salts thereof, for it use as a medicament, in particular for treating a bacterial infection in a subject: (I) In particular, this compound is capable of inhibiting the Mf…
USPTO Abstract
The invention relates to a compound having the general formula (I), or one of the pharmaceutically acceptable salts thereof, for it use as a medicament, in particular for treating a bacterial infection in a subject: (I) In particular, this compound is capable of inhibiting the Mfd activity of bacteria.
Drugs covered by this patent
- Nuzyra (OMADACYCLINE TOSYLATE) · Paratek Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.